We are live on ! Find out more
ECM

EagleClaw Capital Management Portfolio holdings

AUM $745M
1-Year Est. Return 23.99%
This Fund
S&P 500
This Quarter Est. Return
+8.83%
1 Year Est. Return
+23.99%
3 Year Est. Return
+104.02%
5 Year Est. Return
+140.24%
10 Year Est. Return
+617.44%
AUM
$745M
AUM Growth
+$31.3M
Cap. Flow
+$2.59M
Cap. Flow %
0.35%
Top 10 Hldgs %
35.53%
Holding
154
New
9
Increased
42
Reduced
71
Closed
9

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$2.42M
2
BDX icon
Becton Dickinson
BDX
+$2.09M
3
APTV icon
Aptiv
APTV
+$1.74M
4
HON icon
Honeywell
HON
+$1.47M
5
AAPL icon
Apple
AAPL
+$1.38M

Sector Composition

Rank Sector Weight
1 Technology 18.92%
2 Energy 15.97%
3 Industrials 14.1%
4 Consumer Discretionary 10.78%
5 Materials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
51
Berkshire Hathaway Class B
BRK.B
$1.08T
$4.27M 0.57%
8,543
-43
-0.5% -$20.7K
WM icon
52
Waste Management
WM
$87.8B
$4.07M 0.55%
18,271
-50
-0.3% -$11.1K
MSGS icon
53
Madison Square Garden
MSGS
$9.38B
$4.04M 0.54%
10,065
-2,030
-17% -$719K
MRK icon
54
Merck
MRK
$366B
$3.87M 0.52%
30,088
-1,550
-5% -$181K
EMR icon
55
Emerson Electric
EMR
$86.6B
$3.82M 0.51%
26,651
+425
+2% +$59.8K
SYY icon
56
Sysco
SYY
$39.3B
$3.78M 0.51%
45,185
+1,500
+3% +$114K
VRTX icon
57
Vertex Pharmaceuticals
VRTX
$137B
$3.74M 0.5%
7,535
+150
+2% +$66.5K
NVS icon
58
Novartis
NVS
$292B
$3.72M 0.5%
23,712
-3,124
-12% -$468K
PFE icon
59
Pfizer
PFE
$159B
$3.69M 0.5%
153,401
+42,358
+38% +$1.11M
CL icon
60
Colgate-Palmolive
CL
$72.3B
$3.37M 0.45%
36,729
+650
+2% +$56.9K
MKC icon
61
McCormick & Company Non-Voting
MKC
$14.9B
$3.35M 0.45%
66,430
+23,895
+56% +$1.17M
VTI icon
62
Vanguard Morningstar Total Stock Market ETF
VTI
$687B
$3.23M 0.43%
8,732
NVO
63
Novo Nordisk
NVO
$202B
$3.05M 0.41%
63,650
-550
-0.9% -$23.6K
TMO icon
64
Thermo Fisher Scientific
TMO
$230B
$2.75M 0.37%
5,479
-150
-3% -$72K
RSP icon
65
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$2.61M 0.35%
12,285
+1,145
+10% +$234K
UPS icon
66
United Parcel Service
UPS
$89.6B
$2.53M 0.34%
23,543
-3,970
-14% -$413K
COP icon
67
ConocoPhillips
COP
$157B
$2.47M 0.33%
23,802
-450
-2% -$53.3K
MTG icon
68
MGIC Investment
MTG
$6.36B
$2.4M 0.32%
84,950
-4,600
-5% -$123K
MIAX
69
Miami International Holdings
MIAX
$4.27B
$2.15M 0.29%
+57,800
New +$2.58M
LLY icon
70
Eli Lilly
LLY
$1.05T
$2.13M 0.29%
1,772
-25
-1% -$25.5K
MSTR icon
71
Strategy Inc
MSTR
$50.6B
$2.09M 0.28%
24,015
-210
-0.9% -$30.5K
BAC icon
72
Bank of America
BAC
$436B
$2.05M 0.27%
35,900
-15,239
-30% -$810K
SNY icon
73
Sanofi
SNY
$107B
$1.94M 0.26%
45,410
-5,425
-11% -$242K
TXN icon
74
Texas Instruments
TXN
$236B
$1.79M 0.24%
6,015
-150
-2% -$41.6K
VOO icon
75
Vanguard S&P 500 ETF
VOO
$1.03T
$1.76M 0.24%
2,564
-15
-0.6% -$10K

Similar funds

EagleClaw Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, EagleClaw Capital Management held 154 positions worth $745M, up 4.4% from $714M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

EagleClaw Capital Management's Q2 2026 filing shows 9 new, 42 increased, 71 reduced and 9 closed positions. Its largest new stake was Miami International Holdings: 57,800 shares worth $2.15M. The largest sale was Hologic, an estimated $2.42M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Energy and Industrials.

  • EagleClaw Capital Management's largest Q2 2026 buy was Miami International Holdings: 57,800 shares worth $2.15M.
  • EagleClaw Capital Management added most to Intuitive Surgical in Q2 2026, an estimated $4.37M increase.
  • EagleClaw Capital Management's biggest Q2 2026 reduction was Becton Dickinson, cutting an estimated $2.09M.
  • EagleClaw Capital Management fully exited Hologic in Q2 2026, selling an estimated $2.42M.
  • EagleClaw Capital Management's ten largest holdings make up 36% of its $745M portfolio in Q2 2026.
  • EagleClaw Capital Management opened 9 new positions and closed 9 in Q2 2026.
  • EagleClaw Capital Management's portfolio value rose 4.4% quarter-over-quarter to $745M.

Based on EagleClaw Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.